A Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry Eye Syndrome

Exclusion Criteria

• •Chronic or recurrent epistaxis, coagulation disorders or other conditions that, in the opinion of the investigator, may lead to clinically significant increased bleeding
• •Nasal or sinus surgery including nasal cautery or significant trauma
• •Cardiac demand pacemaker, implanted defibrillator or other implanted electronic device
• •Diagnosis of epilepsy
• •Corneal transplant in either or both eyes
• •Participation in any clinical trial with a new active substance or a new device within 30 days of the Screening Visit
• •A woman who is pregnant, planning a pregnancy, or nursing at the Screening Visit